title: [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
authors.forename: P
authors.initials: P
authors.lastname: Layer
authors.forename: K
authors.initials: K
authors.lastname: Dathe
authors.forename: A
authors.initials: A
authors.lastname: Dignass
authors.forename: S
authors.initials: S
authors.lastname: Faiss
authors.forename: P
authors.initials: P
authors.lastname: Galle
authors.forename: M M
authors.initials: MM
authors.lastname: Lerch
authors.forename: P
authors.initials: P
authors.lastname: Malfertheiner
authors.forename: T
authors.initials: T
authors.lastname: Wehrmann
authors.forename: S
authors.initials: S
authors.lastname: Zeuzem
mesh_terms: D001572:Benzofurans / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003248:Constipation / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D054368:Laxatives / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D058828:Serotonin 5-HT4 Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D001572:Benzofurans; D054368:Laxatives; D058828:Serotonin 5-HT4 Receptor Agonists; C406662:prucalopride